Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $180.00M.
ENTERPRISE VALUE (EV)
$180.00M
Standard BioTools Inc.
Market Cap
$292.42M
Enterprise Value (EV)
$180.00M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Standard BioTools Inc. (LAB) | $292.42M | $180.00M |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $291.99M | $240.44M |
| Larimar Therapeutics, Inc. (LRMR)vs › | $290.35M | $202.62M |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.26M | $248.90M |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | $239.49M |
| Benitec Biopharma Inc. (BNTC)vs › | $302.66M | $123.45M |
| Aurora Cannabis Inc. (ACB)vs › | $277.81M | $210.40M |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $307.55M | $138.89M |
| Indaptus Therapeutics, Inc. (INDP)vs › | $275.17M | $267.61M |
| Fate Therapeutics, Inc. (FATE)vs › | $275.08M | $318.33M |
Market Cap
$292.42M
Total Debt
$5.79M
Cash
$118.21M
Enterprise Value
$180.00M
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Why use EV instead of Market Cap?
